Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve Cannabis Corp. has partnered with Miami Mango to launch the Mango Haze strain exclusively for South Florida medical patients. Set to debut in late February, this partnership aims to enhance Trulieve's product offerings, showcasing a commitment to quality and patient care. Trulieve continues to dominate Florida's medical cannabis market, providing a wide range of products, including flower, pre-rolls, oils, and concentrates. The company operates in 11 states, emphasizing growth through its hub strategy and a broad selection of THC and CBD products.
Summary not available.
Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF) announced on January 21, 2022, that it filed a resale registration on Form S-1 with the SEC for Subordinate Voting Shares issued during 2021 acquisitions. A total of 1,577,600 shares were issued to stakeholders for acquisitions involving Patient Centric of Martha's Vineyard, Nature's Remedy, and others. The filing also included a post-effective amendment updating unaudited interim financials and details on Harvest Health & Recreation Inc. acquisitions. Trulieve won't sell any shares or receive proceeds from the registered sales.
Summary not available.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced an expanded partnership with Connected Cannabis Co. to exclusively produce, process, and retail Connected-branded products across Florida. This partnership will enhance Trulieve's offering of premium cannabis strains, already available in Arizona. Products will arrive at Trulieve’s 111 Florida dispensaries later this year. Trulieve, a leading medical cannabis provider in Florida, aims to benefit patients with a wider selection of high-quality products.
Trulieve Cannabis Corp. has launched Live Diamonds by Muse™, a new cannabis concentrate made with hydrocarbon extraction, marking a first for Florida. The initial release of 500 units sold out within 24 hours, with a new batch expected in February 2022. Retailing at $45 for 0.5 grams, the launch strain, White Fire Alien, is noted for its natural flavors. Trulieve emphasizes its commitment to high-quality products, hoping to expand patient access while delivering innovative cannabis solutions.
Summary not available.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the opening of its 160th dispensary in the U.S., located at 1222 Arch St. in Philadelphia. This new establishment, managed by Chamounix Ventures, LLC, offers a range of medical marijuana products including whole flower, vapes, and tinctures. The dispensary is part of Trulieve's commitment to serving Pennsylvania's patient community and will operate Monday to Saturday from 9 AM to 8 PM, and Sundays from 10 AM to 6 PM. Trulieve currently has multiple dispensaries across Pennsylvania, enhancing its market presence.
El Blunto, California's leading blunt producer, is expanding into Arizona through a partnership with Trulieve Cannabis Corp. Starting January 7, 2022, El Blunto products will be exclusively available at all Trulieve-affiliated Harvest retail locations in Arizona for two weeks. This move marks a significant national expansion for El Blunto, known for high-quality cannabis pre-rolls. CEO Q. Ladraa expressed excitement about the collaboration, highlighting Trulieve's approach to customer satisfaction. El Blunto's products will now reach consumers in over 400 dispensaries across California and Arizona.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced its participation in upcoming investor conferences in January 2022. Key events include the ICR Conference on January 10, where CEO Kim Rivers will engage in a fireside chat, followed by the ATB Capital Markets conference on January 13 with President Steve White participating in a panel discussion. Finally, CEO Kim Rivers will also speak at the Needham Growth Conference on January 14. Operating in 11 states, Trulieve is recognized for its innovative products and customer-focused approach.